Cracks in the system: without a national Pharmacare strategy, who is left behind?

14 May 2019 - Lack of public or private insurance, incomplete drug coverage or just plain sky-high prices for drugs that ...

Read more →

Don’t buy pharma’s lies

14 May 2019 - As universal pharmacare gets closer to reality for Canada, drug companies are ramping up their false ...

Read more →

Canadian health care stuck in the ’60s, expert says

14 May 2019 - When Patty De Guia lost her leg to cancer months after giving birth to her third ...

Read more →

In Canada, a little known drug regulator shows its teeth

8 May 2019 - A tiny, little-known government agency is ramping up regulation of Canada’s pharmaceutical industry, seeking to rein in ...

Read more →

Brothers have the same deadly disease but only one gets what their parents hope is life-saving treatment

5 May 2019 - Broken funding system leaves many patients without access to medications they need, health advocates say. ...

Read more →

Why one Nova Scotia boy is being treated with drugs that cost $6 million a year despite a better, cheaper alternative

5 May 2019 - Last summer, Health Canada approved a haemophilia drug called Hemlibra that has the potential to change Callum ...

Read more →

'I took it for my family': Accepting risks of multiple sclerosis drug a part of Sask. couple's love story

3 May 2019 - Sask. just announced it will fund a drug that may relieve rapid degeneration caused by MS. ...

Read more →

SMA patients in Saskatchewan, Canada, gain wider access to Spinraza

1 May 2019 - The Canadian province of Saskatchewan has joined that of Quebec in granting access to Spinraza (nusinersen) ...

Read more →

Canadians will wait longer for new medicines if Health Canada gets its way

23 April 2019 - The intention is to lower prices; the net result will likely be longer wait times before new ...

Read more →

Additional embargo period following revised CDEC recommendations

17 April 2019 - Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to permit an ...

Read more →

Increasing access to new treatments for special patient populations

16 April 2019 - Health Canada is helping Canadians get timely access to new drugs. ...

Read more →

Big pharma might cut research, delay new drugs if Pharmacare means more generics

14 April 2019 - Pharmacare is shaping up as a key campaign issue in the October election, particularly for the Liberals. ...

Read more →

Canada needs to read the fine print on pharma costs

10 April 2019 - The proposed federal price controls for patented medicines will send the wrong signal to Canadian and global ...

Read more →

Ontario woman with rare disease forced to pay hundreds of thousands to cover ‘miracle drug’

3 April 2019 - For 21 years, a Whitby woman and her family have been in and out of hospitals, ...

Read more →

Canada’s amendment to patented drug price regulation: a prescription for global drug cost control?

29 March 2019 - The cost of drugs in the United States has emerged as a focal point for reducing overall ...

Read more →